Skip to main content
OpenTrials
Completed

NCT Number: NCT03290755

Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in Bordeaux

The main objective of this study is to analyse sexual behavior of HIV + MSM in Bordeaux, who have sexually contracted hepatitis C between January 1st 2013, to January 31, 2017. These data will bring some improvement about prevention and maybe reduced the hepatitis C incidence.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Hepatitis C (HCV) is considered in part as a sexually transmitted infection (STI). A marked decrease in its incidence has been observed for several years, coinciding with the availability of new direct acting antiviral treatments (DAA). However, people are increasingly infected with the hepatitis C virus, especially HIV-positive MSM. This increase is explained by new sexual practices that are particularly at high level of risk, despite the widening accessibility of new DAA. Prevention also plays an important role in implementing an effective risk reduction policy. New methods of prevention must therefore be developed. For this purpose, it is imperative to know the natural history of acute hepatitis C, the different behaviours at risk of HCV transmission, and the demonstration of socio-sexual networks (clusters) thanks to virological phylogenetic studies. In order to improve hepatitis C prevention, we wish to establish a descriptive study focusing on :

  • Descriptive analysis of the natural history of hepatitis C,
  • Identification of patient clusters (phylogenetic analysis)
  • Description of the sexual behaviors of infected patients, through a semi-directed interview.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient older than 18 years
  • HIV-1 and/or HIV-2 confirmed Infection
  • Men who have sex with Men
  • Patients included in the "ANRS CO3Aquitaine cohort".
  • HCV contamination documented over the period 01/01/2013 to 01/31/2017 (A positive HCV serology and a HCV plasma RNA positive) AND a negative HCV serology OR a positive HCV serology and a negative plasma RNA before inclusion period
  • A person who has received information about the protocol and has given oral consent and that his / her non-opposition is documented in his / her medical file.

Exclusion criteria

  • Transfusion contamination
  • Substance abuse IV out of SLAM context
  • Refusal to consent to research.

Treatment and study plan

semi-directed interviews

Behavioral

semi-directed interviews in order to collect socio-behavioral data

Primary outcomes

  1. Analyse sexual behaviours among HIV positive MSM in Bordeaux, through semi-directed interviews

    Time frame: At inclusion (day 0)

Secondary outcomes

  1. Identifying socio-sexual networks through phylogenetic analysis

    Time frame: At inclusion (day 0)

  2. Describing the natural history of sexual hepatitis C in HIV positive MSM

    Time frame: At inclusion (day 0)

Sponsors and collaborators

Lead sponsor

University Hospital, Bordeaux

Other

Registry information

Acronym: HEPCSEX

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Sep 25, 2017
Registry last updated
Nov 14, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.